
pmid: 11482908
Human teratocarcinoma cells (Tera‐2) deprived of serum undergo programmed cell death which can be counteracted by simultaneous addition of IGF‐I or IGF‐II. This protective effect of IGFs was specific in the sense that both addition of IGF‐binding protein‐2, and blocking of the IGF‐type I receptor by a specific antibody, both resulted in an increased apoptotic rate.
Teratocarcinoma, Time Factors, Dose-Response Relationship, Drug, Apoptosis, Cell Count, Antibodies, Receptor, IGF Type 1, Insulin-Like Growth Factor II, Tumor Cells, Cultured, Humans, Insulin-Like Growth Factor I, Cell Division
Teratocarcinoma, Time Factors, Dose-Response Relationship, Drug, Apoptosis, Cell Count, Antibodies, Receptor, IGF Type 1, Insulin-Like Growth Factor II, Tumor Cells, Cultured, Humans, Insulin-Like Growth Factor I, Cell Division
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
